The latest price target for Aethlon Medical (NASDAQ:AEMD) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $7.00 expecting AEMD to rise to within 12 months (a possible 1745.99% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Aethlon Medical (NASDAQ:AEMD) was provided by HC Wainwright & Co., and Aethlon Medical reiterated their buy rating.

There is no last upgrade for Aethlon Medical

The last downgrade for Aethlon Medical Inc happened on November 15, 2022 when Maxim Group changed their price target from N/A to N/A for Aethlon Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aethlon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aethlon Medical was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Aethlon Medical (AEMD) rating was a reiterated with a price target of $7.00 to $7.00. The current price Aethlon Medical (AEMD) is trading at is $0.38, which is out of the analyst’s predicted range.